10-Q/A

FORM 10-Q/A

Company: Protalix BioTherapeutics, Inc.
Filed: December 11, 2015
Period of Report: September 30, 2015
Accession Number: 0001144204-15-070554

View Document ↗ View on SEC.gov ↗